-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Merck & Co, Raises Price Target to $145

Benzinga·10/08/2026 10:44:37
Listen to the news
Cantor Fitzgerald analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Neutral and raises the price target from $120 to $145.